Analysts expect that HB Fuller Co (NYSE:FUL) will post earnings of $0.93 per share for the current quarter, according to Zacks. Five analysts have provided estimates for HB Fuller’s earnings. The lowest EPS estimate is $0.91 and the highest is $0.95. HB Fuller reported earnings of $0.90 per share during the same quarter last year, which suggests a positive year-over-year growth rate of 3.3%. The business is scheduled to issue its next earnings report after the market closes on Wednesday, January 22nd.

On average, analysts expect that HB Fuller will report full-year earnings of $3.00 per share for the current fiscal year, with EPS estimates ranging from $2.99 to $3.02. For the next fiscal year, analysts anticipate that the firm will report earnings of $3.50 per share, with EPS estimates ranging from $3.35 to $3.79. Zacks’ earnings per share averages are an average based on a survey of analysts that that provide coverage for HB Fuller.

A number of research firms recently commented on FUL. Citigroup lowered HB Fuller from a “neutral” rating to a “sell” rating and decreased their price target for the stock from $48.00 to $41.00 in a research report on Friday, September 27th. ValuEngine upgraded HB Fuller from a “sell” rating to a “hold” rating in a research report on Tuesday, December 24th. Zacks Investment Research upgraded HB Fuller from a “sell” rating to a “hold” rating in a research report on Wednesday, November 27th. Buckingham Research set a $60.00 price target on HB Fuller and gave the stock a “buy” rating in a research report on Thursday, September 26th. Finally, G.Research restated a “buy” rating on shares of HB Fuller in a research report on Tuesday, October 8th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and two have assigned a buy rating to the company. The company presently has an average rating of “Hold” and an average price target of $49.25.

NYSE FUL traded up $0.36 during trading hours on Thursday, reaching $49.16. 4,976 shares of the company’s stock were exchanged, compared to its average volume of 369,955. The stock has a market cap of $2.45 billion, a PE ratio of 16.37, a price-to-earnings-growth ratio of 1.33 and a beta of 1.57. HB Fuller has a one year low of $39.22 and a one year high of $52.40. The firm has a fifty day moving average of $50.56 and a 200-day moving average of $47.72. The company has a current ratio of 2.36, a quick ratio of 1.55 and a debt-to-equity ratio of 1.77.

In other HB Fuller news, Director Sant R. William Van sold 10,000 shares of the stock in a transaction on Thursday, November 7th. The stock was sold at an average price of $51.67, for a total value of $516,700.00. Following the transaction, the director now directly owns 7,665 shares in the company, valued at approximately $396,050.55. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Zhiwei Cai sold 55,688 shares of the stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $51.80, for a total value of $2,884,638.40. Following the completion of the transaction, the executive vice president now owns 41,104 shares in the company, valued at $2,129,187.20. The disclosure for this sale can be found here. Insiders sold a total of 75,710 shares of company stock worth $3,916,045 over the last quarter. Corporate insiders own 3.46% of the company’s stock.

A number of institutional investors and hedge funds have recently made changes to their positions in the business. BlackRock Inc. boosted its position in HB Fuller by 0.8% in the 2nd quarter. BlackRock Inc. now owns 7,608,478 shares of the specialty chemicals company’s stock valued at $353,034,000 after buying an additional 57,608 shares during the last quarter. Vanguard Group Inc. boosted its position in HB Fuller by 0.7% in the 2nd quarter. Vanguard Group Inc. now owns 5,800,692 shares of the specialty chemicals company’s stock valued at $269,153,000 after buying an additional 38,804 shares during the last quarter. State Street Corp boosted its position in HB Fuller by 2.0% in the 3rd quarter. State Street Corp now owns 4,302,290 shares of the specialty chemicals company’s stock valued at $200,315,000 after buying an additional 83,223 shares during the last quarter. Macquarie Group Ltd. lifted its stake in shares of HB Fuller by 0.6% in the 2nd quarter. Macquarie Group Ltd. now owns 1,377,842 shares of the specialty chemicals company’s stock valued at $63,932,000 after purchasing an additional 8,555 shares during the period. Finally, P2 Capital Partners LLC lifted its stake in shares of HB Fuller by 15.8% in the 2nd quarter. P2 Capital Partners LLC now owns 1,355,499 shares of the specialty chemicals company’s stock valued at $62,895,000 after purchasing an additional 185,113 shares during the period. Hedge funds and other institutional investors own 98.42% of the company’s stock.

HB Fuller Company Profile

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, and other specialty chemical products worldwide. The company operates through five segments: Americas Adhesives, EIMEA, Asia Pacific, Construction Adhesives, and Engineering Adhesives.

Featured Story: Compound Annual Growth Rate (CAGR)

Get a free copy of the Zacks research report on HB Fuller (FUL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for HB Fuller (NYSE:FUL)

Receive News & Ratings for HB Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HB Fuller and related companies with MarketBeat.com's FREE daily email newsletter.